Your browser doesn't support javascript.
loading
Ceftriaxone-Induced Reversible Agranulocytosis: A Case Report and Review of Drug-Induced Agranulocytosis.
Munir, Farrukh; Javaid, Hafiza Wajeeha; Rana, Muhammad Burhan Majeed; Shaukat, Fatima.
Afiliação
  • Munir F; Internal Medicine, WellSpan York Hospital, York, USA.
  • Javaid HW; Internal Medicine, WellSpan York Hospital, York, USA.
  • Rana MBM; Internal Medicine, Queens Hospital Center, New York, USA.
  • Shaukat F; Infectious Disease, University of Maryland (UM) Laurel Medical Center, Laurel, USA.
Cureus ; 14(3): e23226, 2022 Mar.
Article em En | MEDLINE | ID: mdl-35449634
In the modern era of medicine, agranulocytosis is a rare occurrence. Despite significant improvement in patient survival, it still carries significant mortality. Agranulocytosis is most commonly caused by chemotherapeutic agents and numerous non-chemo drugs. As it can develop anytime during treatment and patients can remain asymptomatic, frequent cell count monitoring is an essential tool to make a timely diagnosis. An appropriate drug switch, work up to rule out infection and granulocyte colony-stimulating factor (G-CSF) injection in high-risk cases is the management. The patient should be kept under observation till the resolution of agranulocytosis. We present a case of ceftriaxone-induced agranulocytosis which was completely reversible upon stoppage of drug and granulocyte colony-stimulating factor administration. The pathogenesis of ceftriaxone-induced agranulocytosis is unknown. It is suggested to occur either by an immunologic mechanism or because of direct drug toxicity.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article